Shuta Tomida

12.0k total citations · 3 hit papers
142 papers, 8.6k citations indexed

About

Shuta Tomida is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shuta Tomida has authored 142 papers receiving a total of 8.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Molecular Biology, 54 papers in Oncology and 52 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shuta Tomida's work include Lung Cancer Treatments and Mutations (40 papers), Cancer Genomics and Diagnostics (17 papers) and PI3K/AKT/mTOR signaling in cancer (15 papers). Shuta Tomida is often cited by papers focused on Lung Cancer Treatments and Mutations (40 papers), Cancer Genomics and Diagnostics (17 papers) and PI3K/AKT/mTOR signaling in cancer (15 papers). Shuta Tomida collaborates with scholars based in Japan, United States and United Kingdom. Shuta Tomida's co-authors include Takashi Takahashi, Yasushi Yatabe, Kiyoshi Yanagisawa, Hirotaka Osada, Tetsuya Mitsudomi, Junichi Takamizawa, Yoshio Tatematsu, Hiroyuki Konishi, Hideki Endoh and Yuji Nimura and has published in prestigious journals such as Journal of Clinical Oncology, The EMBO Journal and Bioinformatics.

In The Last Decade

Shuta Tomida

133 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

2004 1.9k citations Junichi Takamizawa, Hiroyuki Konishi et al. Cancer Research profile →
A Polycistronic MicroRNA Cluster, miR-17-92 , Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation

2005 1.3k citations Yoji Hayashita, Hirotaka Osada et al. Cancer Research profile →
Propionibacterium acnes Strain Populations in the Human Skin Microbiome Associated with Acne

2013 528 citations Shuta Tomida, Minghsun Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuta Tomida Japan	39	5.7k	4.2k	1.8k	1.6k	801	142	8.6k
Cheryl Gillett United Kingdom	45	4.2k 0.7×	2.4k 0.6×	4.0k 2.2×	1.2k 0.8×	483 0.6×	123	8.5k
Li Liu China	40	2.9k 0.5×	1.8k 0.4×	1.1k 0.6×	818 0.5×	149 0.2×	218	5.6k
Robert Eferl Austria	33	3.8k 0.7×	1.3k 0.3×	2.0k 1.1×	613 0.4×	241 0.3×	68	6.7k
Yongguang Tao China	43	6.1k 1.1×	4.0k 1.0×	1.3k 0.7×	2.1k 1.3×	81 0.1×	170	8.3k
Andrea Vecchione Italy	44	8.4k 1.5×	6.5k 1.6×	2.1k 1.2×	1.1k 0.7×	121 0.2×	300	12.3k
Rakesh Kumar United States	64	7.5k 1.3×	1.9k 0.5×	3.7k 2.1×	1.1k 0.7×	171 0.2×	295	11.5k
Vivian Wai Yan Lui Hong Kong	40	3.5k 0.6×	1.7k 0.4×	2.5k 1.4×	1.1k 0.7×	93 0.1×	112	6.9k
Ossama Tawfik United States	45	2.5k 0.4×	1.1k 0.3×	2.0k 1.1×	890 0.6×	224 0.3×	216	6.5k
Yuji Hinoda Japan	56	6.5k 1.1×	2.7k 0.6×	3.0k 1.7×	949 0.6×	145 0.2×	272	10.3k
Hirohisa Yano Japan	43	3.1k 0.5×	1.7k 0.4×	2.4k 1.4×	974 0.6×	136 0.2×	283	8.0k

Countries citing papers authored by Shuta Tomida

Since Specialization

Citations

This map shows the geographic impact of Shuta Tomida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuta Tomida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuta Tomida more than expected).

Fields of papers citing papers by Shuta Tomida

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuta Tomida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuta Tomida. The network helps show where Shuta Tomida may publish in the future.

Co-authorship network of co-authors of Shuta Tomida

This figure shows the co-authorship network connecting the top 25 collaborators of Shuta Tomida. A scholar is included among the top collaborators of Shuta Tomida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuta Tomida. Shuta Tomida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nagasaki, Joji, Takamasa Ishino, Youki Ueda, et al.. (2025). Close Spatial Interactions between Cancer Cells and Cancer-Associated Fibroblasts Suppress Antitumor Immunity. Cancer Immunology Research. 13(9). 1471–1484.

Suzawa, Ken, Shuta Tomida, Kazuhiko Shien, et al.. (2024). PAI-1 mediates acquired resistance to MET-targeted therapy in non-small cell lung cancer. PLoS ONE. 19(5). e0300644–e0300644. 5 indexed citations

Ninomiya, Kiichiro, Daisuke Ennishi, Kunio Okamoto, et al.. (2024). Response to Imatinib in a Patient With Gastric Adenocarcinoma With KIT Q556_K558 In-Frame Deletion: A Case Report. JCO Precision Oncology. 8(8). e2400228–e2400228.

Takeuchi, Chihiro, Junichi Sato, Nobutake Yamamichi, et al.. (2023). Marked intestinal trans-differentiation by autoimmune gastritis along with ectopic pancreatic and pulmonary trans-differentiation. Journal of Gastroenterology. 59(2). 95–108. 2 indexed citations

Miura, Akihiro, Daisuke Yamada, Masahiro Nakamura, et al.. (2021). Oncogenic potential of human pluripotent stem cell‐derived lung organoids with HER2 overexpression. International Journal of Cancer. 149(8). 1593–1604. 20 indexed citations

Haratani, Koji, Hidetoshi Hayashi, Shigeki Shimizu, et al.. (2020). Impact of EGFR-TKI Treatment on the Tumor Immune Microenvironment in EGFR Mutation–Positive Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(8). 2037–2046. 172 indexed citations

Namba, Kei, Kazuhiko Shien, Yuta Takahashi, et al.. (2018). Activation of AXL as a Preclinical Acquired Resistance Mechanism Against Osimertinib Treatment in EGFR -Mutant Non–Small Cell Lung Cancer Cells. Molecular Cancer Research. 17(2). 499–507. 71 indexed citations

Matsuo, Kazuhiko, Daisuke Nagakubo, Shinya Yamamoto, et al.. (2017). CCL28-Deficient Mice Have Reduced IgA Antibody–Secreting Cells and an Altered Microbiota in the Colon. The Journal of Immunology. 200(2). 800–809. 31 indexed citations

Kitai, Hidenori, Hiromichi Ebi, Shuta Tomida, et al.. (2016). Epithelial-to-Mesenchymal Transition Defines Feedback Activation of Receptor Tyrosine Kinase Signaling Induced by MEK Inhibition in KRAS -Mutant Lung Cancer. Cancer Discovery. 6(7). 754–769. 108 indexed citations

10.

Nakamura, Yu, Yosuke Togashi, Hirokazu Nakahara, et al.. (2016). Afatinib against Esophageal or Head-and-Neck Squamous Cell Carcinoma: Significance of Activating Oncogenic HER4 Mutations in HNSCC. Molecular Cancer Therapeutics. 15(8). 1988–1997. 13 indexed citations

11.

Terashima, Masato, Yosuke Togashi, Katsuaki Sato, et al.. (2016). Functional Analyses of Mutations in Receptor Tyrosine Kinase Genes in Non–Small Cell Lung Cancer: Double-Edged Sword of DDR2. Clinical Cancer Research. 22(14). 3663–3671. 15 indexed citations

12.

Liu, Jared, Qiao Zhong, Nathanael J. Bangayan, et al.. (2015). The diversity and host interactions of Propionibacterium acnes bacteriophages on human skin. The ISME Journal. 9(9). 2078–2093. 82 indexed citations

13.

Sogabe, Shunsuke, Yosuke Togashi, Hiroaki Kato, et al.. (2014). MEK Inhibitor for Gastric Cancer with MEK1 Gene Mutations. Molecular Cancer Therapeutics. 13(12). 3098–3106. 16 indexed citations

14.

Yanagisawa, Kiyoshi, Hiroyuki Konishi, Chinatsu Arima, et al.. (2010). Novel Metastasis-Related Gene CIM Functions in the Regulation of Multiple Cellular Stress–Response Pathways. Cancer Research. 70(23). 9949–9958. 22 indexed citations

15.

Huang, Qin, Shuta Tomida, Yuji Masuda, et al.. (2010). Regulation of DNA Polymerase POLD4 Influences Genomic Instability in Lung Cancer. Cancer Research. 70(21). 8407–8416. 40 indexed citations

16.

Ebi, Hiromichi, Shuta Tomida, Toshiyuki Takeuchi, et al.. (2009). Relationship of Deregulated Signaling Converging onto mTOR with Prognosis and Classification of Lung Adenocarcinoma Shown by Two Independent In silico Analyses. Cancer Research. 69(9). 4027–4035. 31 indexed citations

17.

Osada, Hirotaka, Shuta Tomida, Yasushi Yatabe, et al.. (2008). Roles of Achaete-Scute Homologue 1 in DKK1 and E-cadherin Repression and Neuroendocrine Differentiation in Lung Cancer. Cancer Research. 68(6). 1647–1655. 83 indexed citations

18.

Tanaka, Hisaaki, Kiyoshi Yanagisawa, Keiko Shinjo, et al.. (2007). Lineage-Specific Dependency of Lung Adenocarcinomas on the Lung Development Regulator TTF-1. Cancer Research. 67(13). 6007–6011. 165 indexed citations

19.

Hayashita, Yoji, Hirotaka Osada, Yoshio Tatematsu, et al.. (2005). A Polycistronic MicroRNA Cluster, miR-17-92 , Is Overexpressed in Human Lung Cancers and Enhances Cell Proliferation. Cancer Research. 65(21). 9628–9632. 1274 indexed citations breakdown →

20.

Takamizawa, Junichi, Hiroyuki Konishi, Kiyoshi Yanagisawa, et al.. (2004). Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival. Cancer Research. 64(11). 3753–3756. 1938 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact